Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quidelortho Corp (QDEL)

Quidelortho Corp (QDEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,329,175
  • Shares Outstanding, K 41,848
  • Annual Sales, $ 1,699 M
  • Annual Income, $ 704,230 K
  • 60-Month Beta 0.02
  • Price/Sales 2.45
  • Price/Cash Flow 5.19
  • Price/Book 1.73
Trade QDEL with:

Options Overview Details

View History
  • Implied Volatility 47.63% ( -3.08%)
  • Historical Volatility 52.03%
  • IV Percentile 8%
  • IV Rank 11.32%
  • IV High 81.29% on 01/25/22
  • IV Low 43.34% on 03/29/22
  • Put/Call Vol Ratio 2.12
  • Today's Volume 428
  • Volume Avg (30-Day) 531
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 16,197
  • Open Int (30-Day) 17,679

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 3.26
  • Number of Estimates 3
  • High Estimate 3.62
  • Low Estimate 2.94
  • Prior Year 0.64
  • Growth Rate Est. (year over year) +409.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.05 +17.49%
on 05/12/22
105.80 -2.22%
on 05/04/22
+1.83 (+1.80%)
since 04/27/22
3-Month
88.05 +17.49%
on 05/12/22
120.61 -14.23%
on 04/08/22
-4.29 (-3.98%)
since 02/25/22
52-Week
88.05 +17.49%
on 05/12/22
180.06 -42.55%
on 12/21/21
-18.05 (-14.86%)
since 05/27/21

Most Recent Stories

More News
QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”),...

QDEL : 103.45 (+3.87%)
Quidel and Ortho Announce Expected Closing of Ortho Transaction

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions,...

OCDX : 17.63 (+0.46%)
QDEL : 103.45 (+3.87%)
Quidel and Ortho Announce Expected Closing of Ortho Transaction

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings...

QDEL : 103.45 (+3.87%)
OCDX : 17.63 (+0.46%)
5 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows to Scoop Up Right Now

The healthcare industry is expected to grow significantly in 2022, thanks to strong demand amid rising chronic diseases, an aging population, and digital integration in healthcare systems. Furthermore,...

ABT : 116.69 (+1.58%)
FMS : 30.45 (+0.26%)
MDT : 99.08 (-0.36%)
QDEL : 103.45 (+3.87%)
SNN : 32.71 (-0.64%)
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously...

QDEL : 103.45 (+3.87%)
Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s...

OCDX : 17.63 (+0.46%)
QDEL : 103.45 (+3.87%)
Quidel (QDEL) Q1 Earnings, Revenues Surpass Estimates, Up Y/Y

Quidel's (QDEL) robust performance across two of its product categories drives its first-quarter 2022 top line.

UNH : 507.11 (+0.97%)
ALKS : 30.54 (+4.02%)
OMCL : 112.99 (+2.98%)
QDEL : 103.45 (+3.87%)
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

QDEL : 103.45 (+3.87%)
APYX : 6.27 (+11.57%)
Quidel Reports First Quarter 2022 Financial Results

Quidel Corporation (NASDAQ: QDEL) , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter...

QDEL : 103.45 (+3.87%)
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD

The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.

CAH : 57.70 (-0.55%)
MCK : 334.96 (-0.43%)
QDEL : 103.45 (+3.87%)
PODD : 235.21 (+2.68%)
NXGN : 18.43 (+1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quidel Corporation is in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company sells its products directly to end users and distributors for professional use. Quidel operates in business segments that develop, manufacture and market it in 4 product segments....

See More

Key Turning Points

3rd Resistance Point 111.39
2nd Resistance Point 107.61
1st Resistance Point 105.53
Last Price 103.45
1st Support Level 99.66
2nd Support Level 95.88
3rd Support Level 93.80

See More

52-Week High 180.06
Fibonacci 61.8% 144.91
Fibonacci 50% 134.05
Fibonacci 38.2% 123.20
Last Price 103.45
52-Week Low 88.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar